Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
DERMthis companyJourney Medical Corporation	$4.60	-16.4×	5.93×	3.05×	-57.16×	-300.3%	59.3%	-13.2%	-18.5%	-35.9%	-14.3%	-6.6%	0.8×	-0.39×	-2.21×	1.79×	0.0%	4	0.73	1	D+
FENCFennec Pharmaceuticals Inc.	$10.64	-21.39×	6.28×	4.93×	-24.6×	-158.5%	91.6%	-14.2%	-21.8%	-27.8%	-10.7%	-5.7%	0×	4.93×	-3.05×	6.34×	0.0%	5	4.08	1	D+
HSDTSolana Company	$1.89	-1.56×	0.21×	10.59×	-1.43×	-610.6%	91.7%	-351.0%	-679.6%	-13.6%	-7.0%	-96.2%	0×	0.18×	-33.26×	10.33×	0.0%	3	1.76	1	C-
OBIOOrchestra BioMed Holdings, Inc.	$5.68	-3.74×	3.13×	5.92×	-3.5×	-202.6%	99.4%	-154.7%	-157.4%	-83.2%	-52.4%	-25.0%	0.25×	0.37×	-45.13×	6.45×	0.0%	3	-2.89	1	D+
OSUROraSure Technologies, Inc.	$3.49	-2.57×	0.52×	1.55×	0.15×	-88.9%	41.9%	-59.2%	-59.8%	-20.2%	-18.6%	-0.0%	0.04×	3.28×	0×	6.58×	0.0%	4	3.11	2	B-
RNACCartesian Therapeutics, Inc.	$7.56	-1.44×	-1.48×	66.95×	-0.55×	-37.2%	100.0%	-3099.9%	-4658.6%	103.2%	-28.4%	-42.4%	-0.1×	0.82×	0×	8.65×	0.0%	2	-4.61	2	C+
Peer median	—	-2.57×	0.52×	5.92×	-1.43×	-158.5%	91.7%	-154.7%	-157.4%	-20.2%	-18.6%	-25.0%	0×	0.82×	-3.05×	6.58×	0.0%	3	1.76	1	—